The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Predicting Bleeding Risk in Atrial Fibrillation Patients Treated with Anticoagulants
A new analysis of serious bleeds among patients who use the blood thinner warfarin to treat atrial fibrillation found that consideration of anticoagulation quality would improve the accuracy of 3 bleeding risk scores.
Lynne Braun from Rush University: Patients Play Key Role In Communicating During Care
Whether it is communicating with friends, loved ones, or their health care providers, being able to communicate effectively can help them feel better about their conditions which can help the overall treatment process.
Dave Dixon from Virginia Commonwealth University: No Magic Pill in Treatment of Obesity
Despite recently approved medications showing improvement over previously used diet pills and other treatments there is still no medicinal cure for obesity and the best hope for patients in many cases is lifestyle changes.
Dave Dixon from Virginia Commonwealth University: Anti-Obesity Agents Provide Some Hope for Patients
The US Food and Drug Administration recently approved some new tools in the fight against obesity. While they provide some help for patients looking to lose weight there are also side effects which doctors and patients patients to consider.
Medical science and research has helped move many parts of cardiology from potentially fatal conditions to more chronic issues for patients and doctors to address. Cholesterol control is moving in that direction thanks to new advancements in medication and surgical options.
5 Employee Problems and How to Solve Them
April 12th 2016You do your best to attract qualified job candidates, ask the right interview questions and ultimately hire the best and the brightest to work at your practice. But, no matter what you do, it is inevitable that you will have problems with your workers from time to time.
Samia Mora from Brigham & Women's Hospital: VLDL and its Role in Future Cardiovascular Care
HDL and LDL may be the more well known components of a patient's cholesterol level but as researchers dig deeper new information is coming to light about very low-density lipoprotein or VLDL.
The ABC-Bleeding Score is a Useful Tool for Patients on Anticoagulation Treatment
Investigators have used data from more than 20,000 atrial fibrillation (AFib) patients to develop and validate a biomarker-based risk score that predicted major bleeding in those patients better than 2 widely used alternatives.
4 Low-Cost Ways to Motivate Your Practice's Employees
April 11th 2016At one point or another, every medical practice will have to deal with unmotivated employees. Unmotivated staff members can cause all sorts of problems, from a slowdown in productivity to decreased profits, poor morale and patient dissatisfaction.
Do You Recognize These 6 Things Which Are Burning You Out at Work?
April 8th 2016Physicians do not usually burn themselves out. The majority of the time it is the work environment which burns out the physician. Certain conditions and circumstances in the workplace can set-up unsuspecting doctors for job related burnout. You can take an on fire, passionate, purpose driven physician and put them in the wrong work environment and you will burn them out.